Emiroglu, NAZANCengiz, FATMA PELİNERDEM, Gul Bahar2020-10-292020-10-292015-01-01Emiroglu N., Cengiz F. P. , ERDEM G. B. , -Serum IL-17A in Behcet-s disease-, POSTEPY DERMATOLOGII I ALERGOLOGII, cilt.32, ss.358-361, 2015http://hdl.handle.net/20.500.12645/25359https://www.termedia.pl/Serum-IL-17A-in-Behcet-s-disease,7,25937,0,1.htmlIntroduction: Behcet-s disease is a chronic multisystem disease with spontaneous remissions and relapses. Several studies show that autoimmune mechanisms play an important role in the development of Behcet-s disease. Activation of T cells and neutrophils is important in the pathogenesis of the disease. Interleukin 17 (IL-17) is a new cytokine that induces several types of cells to secrete proinflammatory cytokines in many inflammatory and autoimmune diseases.info:eu-repo/semantics/openAccessBehcet-s diseaseArticleWOS:0003654045000078494601243210.5114/pdia.2015.5474526759544